North America Topical Wound Agents Market Size, Share & Trends Analysis Report By End-use (Hospitals, Clinics, and Others), By Application (Chronic Wounds and Acute Wounds), By Product (Creams, Gels, Sprays, and Others), By Country and Growth Forecast, 20

North America Topical Wound Agents Market Size, Share & Trends Analysis Report By End-use (Hospitals, Clinics, and Others), By Application (Chronic Wounds and Acute Wounds), By Product (Creams, Gels, Sprays, and Others), By Country and Growth Forecast, 2023 - 2030


The North America Topical Wound Agents Market would witness market growth of 7.3% CAGR during the forecast period (2023-2030).

Topical wound agents refer to a diverse range of products specifically formulated or designed to be applied directly to wounds on the skin's surface. These agents are intended to manage, treat, or aid in healing various types of wounds, including cuts, abrasions, burns, ulcers, and surgical incisions. They play a crucial role in wound care management by providing the conditions for optimal healing and reducing the risk of infection. It works by various mechanisms, including promoting wound healing, reducing inflammation, controlling moisture, preventing infection, and providing a protective barrier against external contaminants. The choice of a topical agent depends on the type and severity of the wound, the individual's medical condition, and the healthcare provider's recommendation.

Multiple wounds exhibit lengthy healing durations and are accompanied by bacterial colonization and infection, frequently resulting in prolonged inflammatory response, and slowed epithelialization. Topical wound care management necessitates the application of sophisticated medical products, including topical wound agents. It is primarily available as sprays, creams, emulsions, and lubricants. In addition to promoting autolytic debridement and smell reduction for the patient's comfort, topical wound agents facilitate quicker healing by ensuring the afflicted area has adequate moisture.

According to Statistics Canada, the 2021 Census recorded 861,000 individuals aged 85 and above, over twofold the figure reported in the 2001 Census. Over the age of 85, the population has increased by 12% since 2016, making it among the age groups experiencing the most rapid development. 2.3% of the population is currently 85 years of age or older. In the twenty-five years leading up to 2046, the elderly population is expected to grow nearly triple to 2.5 million individuals. Therefore, increasing road accidents and the growing elderly population in the region are generating demand in the market.

The US market dominated the North America Topical Wound Agents Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $685.2 million by 2030. The Canada market is experiencing a CAGR of 9.7% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 8.7% during (2023 - 2030).

Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on Application, the market is segmented into Chronic Wounds (Diabetic Foot Ulcers, Pressure Ulcers, Venous Leg Ulcers, and Others), and Acute Wounds (Surgical & Traumatic, and Burns). Based on Product, the market is segmented into Creams, Gels, Sprays, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Smith & Nephew PLC, Teva Pharmaceutical Industries Ltd., Molnlycke Health Care AB, Viatris, Inc. (Mylan N.V.), AstraZeneca PLC, Coloplast Group, Novartis AG, Pfizer Inc., Johnson & Johnson (Johnson & Johnson Services, Inc.), and ConvaTec Group PLC

Scope of the Study

Market Segments covered in the Report:

By End-use
  • Hospitals
  • Clinics
  • Others
By Application
  • Chronic Wounds
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Leg Ulcers
  • Others
  • Acute Wounds
  • Surgical & Traumatic
  • Burns
By Product
  • Creams
  • Gels
  • Sprays
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Smith & Nephew PLC
  • Teva Pharmaceutical Industries Ltd.
  • Molnlycke Health Care AB
  • Viatris, Inc. (Mylan N.V.)
  • AstraZeneca PLC
  • Coloplast Group
  • Novartis AG
  • Pfizer Inc.
  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • ConvaTec Group PLC
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Topical Wound Agents Market, by End-use
1.4.2 North America Topical Wound Agents Market, by Application
1.4.3 North America Topical Wound Agents Market, by Product
1.4.4 North America Topical Wound Agents Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Topical Wound Agents Market by End-use
4.1 North America Hospitals Market by Country
4.2 North America Clinics Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Topical Wound Agents Market by Application
5.1 North America Chronic Wounds Market by Region
5.2 North America Topical Wound Agents Market by Chronic Wounds Type
5.2.1 North America Diabetic Foot Ulcers Market by Country
5.2.2 North America Pressure Ulcers Market by Country
5.2.3 North America Venous Leg Ulcers Market by Country
5.2.4 North America Others Market by Country
5.3 North America Acute Wounds Market by Region
5.4 North America Topical Wound Agents Market by Acute Wounds Type
5.4.1 North America Surgical & Traumatic Market by Country
5.4.2 North America Burns Market by Country
Chapter 6. North America Topical Wound Agents Market by Product
6.1 North America Creams Market by Country
6.2 North America Gels Market by Country
6.3 North America Sprays Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Topical Wound Agents Market by Country
7.1 US Topical Wound Agents Market
7.1.1 US Topical Wound Agents Market by End-use
7.1.2 US Topical Wound Agents Market by Application
7.1.2.1 US Topical Wound Agents Market by Chronic Wounds Type
7.1.2.2 US Topical Wound Agents Market by Acute Wounds Type
7.1.3 US Topical Wound Agents Market by Product
7.2 Canada Topical Wound Agents Market
7.2.1 Canada Topical Wound Agents Market by End-use
7.2.2 Canada Topical Wound Agents Market by Application
7.2.2.1 Canada Topical Wound Agents Market by Chronic Wounds Type
7.2.2.2 Canada Topical Wound Agents Market by Acute Wounds Type
7.2.3 Canada Topical Wound Agents Market by Product
7.3 Mexico Topical Wound Agents Market
7.3.1 Mexico Topical Wound Agents Market by End-use
7.3.2 Mexico Topical Wound Agents Market by Application
7.3.2.1 Mexico Topical Wound Agents Market by Chronic Wounds Type
7.3.2.2 Mexico Topical Wound Agents Market by Acute Wounds Type
7.3.3 Mexico Topical Wound Agents Market by Product
7.4 Rest of North America Topical Wound Agents Market
7.4.1 Rest of North America Topical Wound Agents Market by End-use
7.4.2 Rest of North America Topical Wound Agents Market by Application
7.4.2.1 Rest of North America Topical Wound Agents Market by Chronic Wounds Type
7.4.2.2 Rest of North America Topical Wound Agents Market by Acute Wounds Type
7.4.3 Rest of North America Topical Wound Agents Market by Product
Chapter 8. Company Profiles
8.1 Smith & Nephew PLC
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional and Segmental Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Teva Pharmaceutical Industries Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 SWOT Analysis
8.3 Molnlycke Health Care AB
8.3.1 Company Overview
8.3.2 SWOT Analysis
8.4 Viatris, Inc. (Mylan N.V.)
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 AstraZeneca PLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Coloplast Group
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 SWOT Analysis
8.7 Novartis AG
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Pfizer, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional & Segmental Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 Johnson & Johnson (Johnson & Johnson Services, Inc.)
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental &Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. ConvaTec Group PLC
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings